NCT04081337View on ClinicalTrials.gov

A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

July 9, 2020

Primary Completion Date

May 26, 2022

Study Completion Date

May 26, 2022

Conditions
Obesity
Interventions
DRUG

Tirzepatide

Administered SC

DRUG

Placebo

Administered SC

Trial Locations (1)

70808

Pennington Biomedical Research Center, Baton Rouge

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04081337 - A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide | Biotech Hunter | Biotech Hunter